ASBP
Aspire Biopharma Holdings, Inc.
$5.61
-0.27 (-4.59%)
At close · Jul 7
Market Cap
$7.27M
Shares
1,295,234
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.61
Open$5.91
Day$5.30–5.99
52W$0.11–35.00
Avg vol 30d572K
Short int338K · 26.1% float · 1.0d
Short vol74%
DataApr 2022–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Neutral
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+10%
above
Price vs 50-day avg
+22%
above
RSI (14)
50
neutral
MACD trend
Negative
52-week position
16%
mid-range
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+5%
trailing
6-month return
+48%
trailing
YTD return
+6%
this year
Relative strength
+40%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $5 — 200d above 50d
Institutional flow
Accumulating
+13 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
26.09% of float · ▲ +172.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
13 holders — 13F breadth
Squeeze score
56
elevated · 0–100
Fundamentals
Gross margin
-2%
EPS growth
−762%
Y/Y
Balance sheet
$1.0M
net cash
Quant / Vol
risk profile
Volatility
2898%
annualized · 1-yr
Max drawdown
−99%
past year
ATR
14.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+10%
Bullish
Price vs 50-day avg
+22%
Bullish
RSI (14)
50
Neutral
MACD trend
Negative
Bearish
52-week position
16%
Neutral
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $5 › 200d $5 — 200d above 50d
Institutional flow
Accumulating
+13 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
26.09% of float · ▲ +172.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
13 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $0
Now $6 · 16%
52-wk high $35
vs 200-day avg +10%
vs 50-day avg +22%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ASBP
this stock
Aspire Biopharma Holdings, Inc.
|
$7.27M | +6.3% | — | — | 26.1% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 29.6 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.50B | -14.0% | +20.8% | 16.2 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
13
- % held
- 27.3%
- Net QoQ
- +353.3K sh
- Top holder
- HIGHBRIDGE CAPITAL MANAGE…
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ASBP | -8.6% | +5.1% | +47.6% | +5.1% | +6.3% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | -9.5% | +3.7% | +40.1% | +4.9% | -3.4% |